Why the ResApp (ASX:RAP) share price is flying 25% higher today

Respiratory illnesses have come under increasing scrutiny during the pandemic.

| More on:
three excited doctors with hands in the air

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ResApp Health Ltd (ASX: RAP) share price is flying higher today, up 25%.

The company – which provides health care solutions for respiratory diseases via smartphone applications – emerged from Monday's trading halt this morning.

And investors appear to be driving the ResApp share price higher following 2 separate market announcements. We take a look at those below.

What did ResApp announce?

ResApp's share price is soaring after the ASX healthcare share reported it has signed a software licence agreement with Indonesian-based telehealth company Alodokter.

Under the agreement, Alodokter, the largest provider of telehealth services in Indonesia, will integrate ResAppDx in its chat and telehealth services.

Alodokter plans to launch ResAppDx, a smartphone-based acute respiratory diagnostic test, on its platform before 1 December. According to the announcement, that platform connects more than 50,000 doctors and 1,500 hospitals and clinics with millions of Indonesian patients.

Commenting on the software licence agreement, Alodokter's CEO Nathanael Faibis said, "ResApp's technology will allow us to serve more patients in a remote, telehealth setting and effectively diagnose and treat their respiratory disease."

Faibis added that his company was "very impressed with the simplicity, ease of use and accuracy of ResAppDx".

ResApp's CEO Tony Keating said, "This partnership will create value for ResApp, Alodokter and our collective shareholders and stakeholders."

The agreement remains subject to approval from Indonesian regulators. ResApp said it expects to obtain that approval this quarter.

What was ResApp's other news?

The ResApp share price also looks to be getting a lift from a separate licencing announcement this morning.

The company reported it has signed a commercial licence agreement with Medgate AG to use ResAppDx on Medgate's telehealth platform in Europe and the Philippines.

Medgate provides telehealth services and operates the largest telemedical centre run by doctors in Europe.

Keating commented:

Medgate is a long-standing, global leader in telehealth and we are pleased to enter into a commercial licence agreement that provides ResAppDx for the benefit of their clinicians and patients.

We are delighted to secure our first commercial telehealth license agreement in Europe and receive a positive endorsement of ResAppDx by such a successful leader in the telehealth field.

The agreement is for an initial 1-year term.

ResApp share price snapshot

Despite today's surge, the ResApp share price remains down 63% over the past 12 months, a period which has seen the All Ordinaries Index (ASX: XAO) gain 26%.

Year-to-date, ResApp's share price has continued to struggle, down 40%.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Two doctors wearing white coats look closely at a medical imaging x-ray as the share prices of ASX 200 healthcare shares improve in FY23
Healthcare Shares

Pro Medicus shares climb 33% in less than a month, have I missed the dip?

Pro Medicus shares have soared. Is it the right time to invest?

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords share just rocketed 19% on BIG news

Investors are sending this ASX All Ords share flying on Monday. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Healthcare Shares

Why is this ASX All Ords stock surging 14% today?

This stock is starting the week strongly. But why? Let's find out.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Healthcare Shares

Guess which ASX All Ords stock is rocketing 58% on big US news

What is getting investors excited today? Let's find out.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

3 reasons to buy this quality ASX 200 healthcare share today

A leading expert expects this outperforming ASX 200 healthcare share will keep running hot.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

Brokers tip 4 ASX 200 healthcare shares to buy now

Healthcare is a defensive sector that can provide useful cover for investors when the market is volatile.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

How Trump's tariffs have created 'upside potential' for CSL shares

A leading expert says CSL shares are now looking ‘cheap’.

Read more »

Shot of a young scientist looking stressed out while working on a computer in a lab.
Healthcare Shares

Telix shares crash 8% on US FDA blow

This high-flying stock has been hit with some bad news.

Read more »